HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
35 hedge funds and large institutions have $20.2M invested in HOOKIPA Pharma in 2024 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 14 closing their positions.
33.41% more ownership
Funds ownership: 3.65% → 37.06% (+33%)
3% less capital invested
Capital invested by funds: $20.9M → $20.2M (-$641K)
13% less funds holding
Funds holding: 40 → 35 (-5)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
36% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 14
82% less call options, than puts
Call options by funds: $155K | Put options by funds: $868K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$280K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$257K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$62.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$59K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$24.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$3.35M |
| 2 |
Morgan Stanley
New York
|
-$85.3K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$75.1K |
| 4 |
Two Sigma Investments
New York
|
-$71.9K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$38.2K |
HOOK Hedge Fund Activity: Q3 2024 in Review
35 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q3 2024, worth a combined $20.2M — down 3.1% from $20.9M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of HOOK and 9 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 10 added.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $280K. The largest seller was Artal Group, exiting entirely with an estimated $3.35M sold.
- 35 institutional investors held HOOKIPA Pharma (HOOK) as of Q3 2024, down from 40 in Q2 2024.
- Funds reported $20.2M of HOOKIPA Pharma stock for Q3 2024, down 3.1% quarter-over-quarter.
- 9 funds opened new HOOKIPA Pharma positions in Q3 2024 and 14 closed out, a net change of -5 holders.
- The largest HOOKIPA Pharma buyer in Q3 2024 was Ikarian Capital, an estimated $280K added.
- The largest HOOKIPA Pharma seller in Q3 2024 was Artal Group, an estimated $3.35M sold.
Based on aggregated 13F filings for Q3 2024.